CMND: Clearmind Medicine Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-12 | 13G amendment | Iroquois Capital Management, LLC | 9.99% | SEC |
Institutional ownership (Q2 2026)
6 institutions reported holding $31K of Clearmind Medicine Inc. on Form 13F (0 the quarter before). 6 opened a new position and 0 sold out. Shares held by institutions: new.
| Largest holders | Shares | Value |
|---|---|---|
| CITADEL ADVISORS LLC | 11,710 | $26K |
| AdvisorShares Investments LLC | 1,169 | $3K |
| MORGAN STANLEY | 700 | $2K |
| ROYAL BANK OF CANADA | 287 | $1K |
| HRT FINANCIAL LP | 35,143 | $77 |
| Caitong International Asset Management Co., Ltd | 1 | $2 |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.